Upgrade to SI Premium - Free Trial

Karyopharm Therapeutics (KPTI) PT Lowered to $8 at H.C. Wainwright

March 25, 2026 6:54 AM
(Updated - March 25, 2026 6:55 AM EDT)

H.C. Wainwright analyst Robert Burns lowered the price target on Karyopharm ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change